Cargando…
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance
BACKGROUND: High-throughput assays for the SARS-CoV-2 virus are critical to increasing test capacity and slowing the spread of COVID-19. Abbott Molecular developed and received emergency use authorization (EUA) to deploy the new RealTime SARS-CoV-2 assay, run on the automated m2000sp/rt system. OBJE...
Autores principales: | Degli-Angeli, Emily, Dragavon, Joan, Huang, Meei-Li, Lucic, Danijela, Cloherty, Gavin, Jerome, Keith R., Greninger, Alexander L., Coombs, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7395853/ https://www.ncbi.nlm.nih.gov/pubmed/32504946 http://dx.doi.org/10.1016/j.jcv.2020.104474 |
Ejemplares similares
-
Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity
por: Berg, Michael G., et al.
Publicado: (2021) -
Comparison of Roche TaqMan v.2.0, Abbott RealTime and Modified Abbott Residual Viremia Assays in Testing of Routine Samples for Viremia Monitoring in HIV Care
por: Mckinnon, John, et al.
Publicado: (2017) -
Analytical Evaluation of the Abbott RealTime CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Rectal and Pharyngeal Swabs
por: Adamson, Paul C., et al.
Publicado: (2020) -
Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIV
por: Saavedra, Belén, et al.
Publicado: (2021) -
Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)